Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.

about

Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.

Item

http://www.wikidata.org/entity/Q41573474

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comprehensive Study of Multipl ...... ubsequent Fibrosis in SD Rats.

@en

type

Item

label

Comprehensive Study of Multipl ...... ubsequent Fibrosis in SD Rats.

@en

prefLabel

Comprehensive Study of Multipl ...... ubsequent Fibrosis in SD Rats.

@en

P1476

Comprehensive Study of Multipl ...... ubsequent Fibrosis in SD Rats.

@en

P2093

Ji Ma

http://www.w3.org/2001/XMLSchema#string

Jing Shang

http://www.w3.org/2001/XMLSchema#string

Lixin Wei

http://www.w3.org/2001/XMLSchema#string

Lulu Wang

http://www.w3.org/2001/XMLSchema#string

Maoru Li

http://www.w3.org/2001/XMLSchema#string

Minxuan Cai

http://www.w3.org/2001/XMLSchema#string

Shengcun Li

http://www.w3.org/2001/XMLSchema#string

Susu Wu

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges

Use and abuse of HOMA modeling

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.

NAFLD, NASH and liver cancer.

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.

Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death

Hepatic Steatosis as a Marker of Metabolic Dysfunction.

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

P31

scholarly article

P356

10.3390/IJMS18081681

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28820447

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5578071

http://www.w3.org/2001/XMLSchema#string